Catalyst Wire Dossier Catalyst Wire Dossier

danoprevir/ritonavir fixed-dose combination tablets

danoprevir/ritonavir · Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for danoprevir/ritonavir fixed-dose combination tablets, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of The Relative Bioavailability of Ritonavir-Boosted Danoprevir Fixed Dose Combination Tablets in Healthy Volunteers [Phase 1]

See pricing